A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active Ulcerative Colitis
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2017
At a glance
- Drugs GED 0507 34 Levo (Primary)
- Indications Ulcerative colitis
- Focus Proof of concept; Therapeutic Use
- Acronyms SEGMENT
- 23 Aug 2017 This trial has been Discontinued in Bulgaria (end date: 31 Jul 2017).
- 22 Aug 2017 Status changed from recruiting to discontinued.
- 15 Aug 2017 This trial has been Discontinued in Hungary, according to European Clinical Trials Database